ID   OLR1_BOVIN              Reviewed;         270 AA.
AC   P79391;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   25-MAY-2022, entry version 122.
DE   RecName: Full=Oxidized low-density lipoprotein receptor 1;
DE            Short=Ox-LDL receptor 1;
DE   AltName: Full=Lectin-like oxidized LDL receptor 1;
DE            Short=LOX-1;
DE            Short=Lectin-like oxLDL receptor 1;
DE            Short=bLOX-1;
DE   AltName: Full=Lectin-type oxidized LDL receptor 1;
DE   Contains:
DE     RecName: Full=Oxidized low-density lipoprotein receptor 1, soluble form A;
DE   Contains:
DE     RecName: Full=Oxidized low-density lipoprotein receptor 1, soluble form B;
GN   Name=OLR1; Synonyms=LOX1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=9052782; DOI=10.1038/386073a0;
RA   Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y.,
RA   Tanaka T., Miwa S., Katsura Y., Kita T., Masaki T.;
RT   "An endothelial receptor for oxidized low-density lipoprotein.";
RL   Nature 386:73-77(1997).
RN   [2]
RP   PROTEIN SEQUENCE OF 87-91 AND 90-94, AND IDENTIFICATION OF SOLUBLE FORMS.
RX   PubMed=10712396; DOI=10.1161/01.atv.20.3.715;
RA   Murase T., Kume N., Kataoka H., Minami M., Sawamura T., Masaki T., Kita T.;
RT   "Identification of soluble forms of lectin-like oxidized LDL receptor-1.";
RL   Arterioscler. Thromb. Vasc. Biol. 20:715-720(2000).
RN   [3]
RP   FUNCTION.
RX   PubMed=9689115; DOI=10.1073/pnas.95.16.9535;
RA   Oka K., Sawamura T., Kikuta K., Itokawa S., Kume N., Kita T., Masaki T.;
RT   "Lectin-like oxidized low-density lipoprotein receptor 1 mediates
RT   phagocytosis of aged/apoptotic cells in endothelial cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:9535-9540(1998).
RN   [4]
RP   FUNCTION.
RX   PubMed=10618423; DOI=10.1073/pnas.97.1.360;
RA   Kakutani M., Masaki T., Sawamura T.;
RT   "A platelet-endothelium interaction mediated by lectin-like oxidized low-
RT   density lipoprotein receptor-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:360-364(2000).
RN   [5]
RP   MUTAGENESIS OF LYS-262; LYS-263 AND ASN-265.
RX   PubMed=11284714; DOI=10.1042/0264-6021:3550289;
RA   Chen M., Narumiya S., Masaki T., Sawamura T.;
RT   "Conserved C-terminal residues within the lectin-like domain of LOX-1 are
RT   essential for oxidized low-density-lipoprotein binding.";
RL   Biochem. J. 355:289-296(2001).
RN   [6]
RP   GLYCOSYLATION.
RX   PubMed=10692464; DOI=10.1074/jbc.275.9.6573;
RA   Kataoka H., Kume N., Miyamoto S., Minami M., Murase T., Sawamura T.,
RA   Masaki T., Hashimoto N., Kita T.;
RT   "Biosynthesis and post-translational processing of lectin-like oxidized low
RT   density lipoprotein receptor-1 (LOX-1). N-linked glycosylation affects
RT   cell-surface expression and ligand binding.";
RL   J. Biol. Chem. 275:6573-6579(2000).
RN   [7]
RP   FUNCTION.
RX   PubMed=10777555; DOI=10.1074/jbc.275.17.12633;
RA   Cominacini L., Pasini A.F., Garbin U., Davoli A., Tosetti M.L.,
RA   Campagnola M., Rigoni A., Pastorino A.M., Lo Cascio V., Sawamura T.;
RT   "Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in
RT   endothelial cells induces the activation of NF-kappaB through an increased
RT   production of intracellular reactive oxygen species.";
RL   J. Biol. Chem. 275:12633-12638(2000).
RN   [8]
RP   FUNCTION.
RX   PubMed=11290792; DOI=10.4049/jimmunol.166.8.5108;
RA   Shimaoka T., Kume N., Minami M., Hayashida K., Sawamura T., Kita T.,
RA   Yonehara S.;
RT   "LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria.";
RL   J. Immunol. 166:5108-5114(2001).
RN   [9]
RP   MUTAGENESIS OF 205-ARG-LYS-206; ARG-225; ARG-232 AND ARG-244.
RX   PubMed=11423119; DOI=10.1016/s0014-5793(01)02557-1;
RA   Chen M., Inoue K., Narumiya S., Masaki T., Sawamura T.;
RT   "Requirements of basic amino acid residues within the lectin-like domain of
RT   LOX-1 for the binding of oxidized low-density lipoprotein.";
RL   FEBS Lett. 499:215-219(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=11821070; DOI=10.1016/s0014-5793(01)03325-7;
RA   Jono T., Miyazaki A., Nagai R., Sawamura T., Kitamura T., Horiuchi S.;
RT   "Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as
RT   an endothelial receptor for advanced glycation end products (AGE).";
RL   FEBS Lett. 511:170-174(2002).
CC   -!- FUNCTION: Receptor that mediates the recognition, internalization and
CC       degradation of oxidatively modified low density lipoprotein (oxLDL) by
CC       vascular endothelial cells. OxLDL is a marker of atherosclerosis that
CC       induces vascular endothelial cell activation and dysfunction, resulting
CC       in pro-inflammatory responses, pro-oxidative conditions and apoptosis.
CC       Its association with oxLDL induces the activation of NF-kappa-B through
CC       an increased production of intracellular reactive oxygen and a variety
CC       of pro-atherogenic cellular responses including a reduction of nitric
CC       oxide (NO) release, monocyte adhesion and apoptosis. In addition to
CC       binding oxLDL, it acts as a receptor for the HSP70 protein involved in
CC       antigen cross-presentation to naive T-cells in dendritic cells, thereby
CC       participating in cell-mediated antigen cross-presentation. Also
CC       involved in inflammatory process, by acting as a leukocyte-adhesion
CC       molecule at the vascular interface in endotoxin-induced inflammation.
CC       Also acts as a receptor for advanced glycation end (AGE) products,
CC       activated platelets, monocytes, apoptotic cells and both Gram-negative
CC       and Gram-positive bacteria. {ECO:0000269|PubMed:10618423,
CC       ECO:0000269|PubMed:10777555, ECO:0000269|PubMed:11290792,
CC       ECO:0000269|PubMed:11821070, ECO:0000269|PubMed:9052782,
CC       ECO:0000269|PubMed:9689115}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. May form a hexamer composed of 3
CC       homodimers. Interacts with HSP70 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor
CC       {ECO:0000250}. Cell membrane {ECO:0000269|PubMed:9052782}; Single-pass
CC       type II membrane protein {ECO:0000269|PubMed:9052782}. Membrane raft
CC       {ECO:0000250}. Secreted {ECO:0000269|PubMed:9052782}. Note=Localization
CC       to membrane rafts requires palmitoylation (By similarity). A secreted
CC       form also exists. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in endothelial cells, aortic
CC       intima and lung. Expressed at low level in other tissues.
CC       {ECO:0000269|PubMed:9052782}.
CC   -!- DOMAIN: The cytoplasmic region is required for subcellular sorting on
CC       the cell surface. {ECO:0000250}.
CC   -!- DOMAIN: The C-type lectin domain mediates the recognition and binding
CC       of oxLDL.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:10692464}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D89049; BAA19005.1; -; mRNA.
DR   RefSeq; NP_776557.1; NM_174132.2.
DR   AlphaFoldDB; P79391; -.
DR   SMR; P79391; -.
DR   STRING; 9913.ENSBTAP00000005975; -.
DR   BindingDB; P79391; -.
DR   PaxDb; P79391; -.
DR   GeneID; 281368; -.
DR   KEGG; bta:281368; -.
DR   CTD; 4973; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   InParanoid; P79391; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0005041; F:low-density lipoprotein particle receptor activity; IBA:GO_Central.
DR   GO; GO:0008219; P:cell death; IBA:GO_Central.
DR   GO; GO:0002376; P:immune system process; IEA:UniProtKB-KW.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0042157; P:lipoprotein metabolic process; IBA:GO_Central.
DR   CDD; cd03593; CLECT_NK_receptors_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR033992; NKR-like_CTLD.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell membrane; Cleavage on pair of basic residues;
KW   Coiled coil; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Immunity; Inflammatory response; Lectin; Lipoprotein; Membrane; Palmitate;
KW   Receptor; Reference proteome; Secreted; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..270
FT                   /note="Oxidized low-density lipoprotein receptor 1"
FT                   /id="PRO_0000017440"
FT   CHAIN           87..270
FT                   /note="Oxidized low-density lipoprotein receptor 1, soluble
FT                   form A"
FT                   /id="PRO_0000017441"
FT   CHAIN           90..270
FT                   /note="Oxidized low-density lipoprotein receptor 1, soluble
FT                   form B"
FT                   /id="PRO_0000017442"
FT   TOPO_DOM        1..33
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        34..56
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        57..270
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          147..261
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          57..146
FT                   /note="Neck"
FT   COILED          85..135
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1..17
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           42
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        69
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        135
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        140..151
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DISULFID        168..260
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DISULFID        239..252
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   MUTAGEN         205..206
FT                   /note="RK->AA: Does not affect oxLDL binding. Impairs oxLDL
FT                   binding; when associated with A-225; A-232 and A-234."
FT                   /evidence="ECO:0000269|PubMed:11423119"
FT   MUTAGEN         225
FT                   /note="R->A: Reduces oxLDL binding. Impairs oxLDL binding;
FT                   when associated with A-205; A-206; A-225; A-232 and A-234."
FT                   /evidence="ECO:0000269|PubMed:11423119"
FT   MUTAGEN         232
FT                   /note="R->A: Does not affect oxLDL binding. Impairs oxLDL
FT                   binding; when associated with A-205; A-206; A-225 and
FT                   A-234."
FT                   /evidence="ECO:0000269|PubMed:11423119"
FT   MUTAGEN         244
FT                   /note="R->A: Does not affect oxLDL binding. Impairs oxLDL
FT                   binding; when associated with A-205; A-206; A-225 and
FT                   A-232."
FT                   /evidence="ECO:0000269|PubMed:11423119"
FT   MUTAGEN         262
FT                   /note="K->A: Impairs the binding to oxLDL."
FT                   /evidence="ECO:0000269|PubMed:11284714"
FT   MUTAGEN         263
FT                   /note="K->A: Impairs the binding to oxLDL."
FT                   /evidence="ECO:0000269|PubMed:11284714"
FT   MUTAGEN         265
FT                   /note="N->D: Impairs the binding to oxLDL."
FT                   /evidence="ECO:0000269|PubMed:11284714"
SQ   SEQUENCE   270 AA;  30892 MW;  6055B6881AD7053D CRC64;
     MTVDDPKGMK DQLDQKPNGK TAKGFVSSWR WYPAAVTLGV LCLGLLVTVI LLILQLSQVS
     DLIKKQQANI THQEDILEGQ ILAQRRSEKS AQESQKELKE MIETLAHKLD EKSKKLMELH
     RQNLNLQEVL KEAANYSGPC PQDWLWHEEN CYQFSSGSFN WEKSQENCLS LDAHLLKINS
     TDELEFIQQM IAHSSFPFWM GLSMRKPNYS WLWEDGTPLT PHLFRIQGAV SRMYPSGTCA
     YIQRGTVFAE NCILTAFSIC QKKANLLRAQ
//
